Evolutionary Tree Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.19M | Sell |
|
|||||
|
2025
Q1 | $3.22M | Sell |
|
|||||
|
2024
Q4 | $4.15M | Sell |
|
|||||
|
2024
Q3 | $4.89M | Buy |
|
|||||
|
2024
Q2 | $3.39M | Buy |
|
|||||
|
2024
Q1 | $2.06M | Sell |
|
|||||
|
2023
Q4 | $2.11M | Buy |
|
|||||
|
2023
Q3 | $1.56M | Sell |
|
|||||
|
2023
Q2 | $1.51M | Buy |
|
|||||
|
2023
Q1 | $1.14M | Sell |
|
|||||
|
2022
Q4 | $2.73M | Sell |
|
|||||
|
2022
Q3 | $3.01M | Buy |
|
|||||
|
2022
Q2 | $2.11M | Sell |
|
|||||
|
2022
Q1 | $4.4M | Sell |
|
|||||
|
2021
Q4 | $5.75M | Buy |
|
|||||
|
2021
Q3 | $3.71M | Buy |
|
|||||
|
2021
Q2 | $2.29M | Buy |
|
|||||
|
2021
Q1 | $2.16M | Buy |
|
|||||
|
2020
Q4 | $2.04M | Buy |
|